BIG
XERS icon

Brooklyn Investment Group’s Xeris Biopharma Holdings XERS Stock Holding History

Brooklyn Investment Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.1K Sell
10,534
-1,661
-14% -$11K ﹤0.01% 1816
2025
Q4 		$90.6K Buy
+12,195
New +$96K ﹤0.01% 1473

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brooklyn Investment Group's XERS Position: Q1 2026 in Review

Brooklyn Investment Group reduced its Xeris Biopharma Holdings (XERS) stake by 14% in Q1 2026, selling an estimated $11K and leaving 10,534 shares worth $61.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Brooklyn Investment Group first reported a position in XERS in Q4 2025 and has held it in 2 quarters since. The position peaked at $90.6K in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Brooklyn Investment Group held 10,534 shares of Xeris Biopharma Holdings worth $61.1K as of Q1 2026.
  • Brooklyn Investment Group sold 1,661 Xeris Biopharma Holdings shares in Q1 2026, an estimated $11K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1816 holding.
  • Brooklyn Investment Group first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 2 quarters since.
  • Brooklyn Investment Group's Xeris Biopharma Holdings position peaked at $90.6K in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.